Nanga Kwinana

Nanga Kwinana

Johannesburg, South Africa
T: +27 11 669 9609
  • Overview
  • Experience


Nanga Kwinana is a partner in the Corporate department of our Johannesburg office, and a member of the M&A practice.

He specialises in mergers and acquisitions, equity capital markets and securities law. He has advised private and public companies on several domestic and cross border acquisitions, disposals, empowerment transactions, engagements with regulators (such as the B-BBEE Commission), general corporate commercial and governance matters as well as equity capital raising exercises, including initial public offerings, secondary listings, rights offers and accelerated bookbuild offerings. Nanga has a wealth of experience in advising on cross-border transactions involving companies listed on multiple securities exchanges.

Nanga joined the Firm in 2014 and recently practiced at the New York office of international law firm, Sullivan & Cromwell LLP where he advised on both mergers and acquisitions and capital markets transactions.

Nanga has an LLB degree from the Nelson Mandela Metropolitan University.

Specialist Services

Relevant Experience

Some of Nanga’s relevant transactional experience includes advising:

  • Standard Bank Group Limited in its offer to acquire: (i) the remaining Liberty Holdings Limited issued ordinary shares held by Liberty minority shareholders; and (ii) all of the issued Liberty preference shares.
  • Imperial Logistics Limited in respect of the DP World Logistics FZE offer to acquire: (i) the issued ordinary shares of Imperial; and (ii) the issued deferred ordinary shares of Imperial.
  • Linde Plc in its recent take-private of its JSE and Namibian Stock Exchange-listed subsidiary, African Oxygen Limited, by way of a scheme of arrangement.
  • Starwood Capital Group-subsidiary, SOF-12 Cambridge Bidco Limited in its recent acquisition of all the issued shares of Isle of Man-incorporated RDI REIT plc, which were listed on the London Stock Exchange and the JSE.
  • Rovensa, the Partners Group and Bridgepoint-controlled private equity group, in its acquisition of the Oro Agri group of companies from Omnia Holdings Limited.
  • ABSA Bank and P. Morgan, in their role as joint bookrunners, in relation to the ZAR 3,5 billion accelerated bookbuild primary offering by Harmony Gold Mining Company Limited.
  • Pepkor Holdings Limited in relation to the issue of 172,500,000 new ordinary shares through an accelerated bookbuild. Rand Merchant Bank, a division of FirstRand Bank Limited and Morgan Stanley & Co. International Plc acted as joint global coordinators and joint bookrunners of the placement.
  • Sphere Holdings, the Black-owned private equity group in respect of various investments and restructurings and general corporate commercial matters.
  • Royal Bafokeng Platinum in relation to its 2017 ZAR 1,2 billion convertible bond offering, its 2018 accelerated placement, and the 2019 rights offer.
  • Datatec Limited, in respect of company law and capital markets advice and general corporate commercial matters.
  • Rand Merchant Bank, in its role as sole bookrunner, in relation to the ZAR 2 billion accelerated bookbuild primary offering by Pepkor Holdings Limited.
  • Rand Merchant Bank in relation to the 2016 listing of EPE Capital Partners Ltd on the JSE.
  • the Joint Bookrunners for The Foschini Group, in relation to its accelerated bookbuild to raise approximately ZAR 2,5 billion to repay a bridge facility. Our clients were Rand Merchant Bank and Morgan Stanley.
  • Imperial Holdings in respect of the unbundling of Motus Holdings, a diversified automotive business, to its shareholders and the simultaneous listing of the ordinary shares in Motus Holdings on the securities exchange operated by the JSE. As part of the transaction, the group also undertook a debt restructuring with its funders, such that after the unbundling, each of Imperial Holdings and Motus Holdings have their balance sheets and funding programmes operating on a stand-alone basis.
  • Imperial Holdings in respect of a repurchase of all its outstanding preference shares from shareholders by way of a scheme of arrangement, a key part of the restructuring of the company’s capital structure.
  • the Bookrunners for Main Street 333 (RF) (Pty) Ltd (MS) in the ZAR 2,45 billion private placement of approximately 19 million of MS’s Exxaro Resources The bookrunners were Absa Bank, Deutsche Bank, Basis Points Capital, Vunani Securities and Nedbank.
  • Investec, in its role as sole bookrunner to Stor-Age Property REIT Limited in relation to its 2020 accelerated bookbuild offering that raised approximately ZAR 250 million.
  • Investec, in its role as sole bookrunner to Blue Label Telecoms, in relation to its accelerated bookbuild to raise approximately ZAR 900 million to settle part of the acquisition consideration in terms of a sale, subscription and repurchase agreement.
  • Merrill Lynch International, J.P. Morgan, Goldman Sachs, BNP Paribas and Avior Capital Markets, in relation to their role as underwriters in respect of the unbundling of Quilter Plc from Old Mutual Plc and the placing and listing of Quilter Plc shares on the London Stock Exchange, as a primary listing, and the JSE, as a secondary listing.
  • ABSA Bank Limited, in its role as the sole bookrunner to SA Corporate Real Estate in relation to its 2017 general issue of shares for cash aimed at raising capital (ZAR 600 million) to fund potential acquisitions and/ or future capital expenditure.
  • Riskowitz Value Fund, a limited partnership formed in the state of Delaware, USA, on its underwriting the ZAR 398 million renounceable rights offer by Taste Holdings.
  • Tata Communications Limited in respect of the ZAR 6,55 billion disposal of Neotel to Liquid Telecommunications Holdings and Royal Bafokeng Holdings.
  • various empowerment shareholders of Aspen Pharmacare in relation to the 2015 unwinding of the Aspen Pharmacare empowerment structure and private placement of Aspen Pharmacare shares to create liquidity for the empowerment shareholders.
  • Panasonic Healthcare Co. Ltd in respect of the South African aspects of its acquisition of the global diabetes care business of Bayer AG.